HCWB: hcwbiologics.com Kompaniya qiymatining sof foydaga nisbati
Yoshga bog'liq patologiyalar uchun davolash usullarini ishlab chiqish iqtisodiy sikllardan mustaqil qolmoqda, bu esa aktivlarga yuqori chidamlilikni ta'minlaydi. -0.10 ko'rsatkichi bilan HCW Biologics Inc. (HCWB) kompaniyasining bozor qiymatini aks ettiruvchi ushbu grafik onkologiya va yallig'lanishga qarshi kurashda qo'llaniladigan oqsillarning patent himoyasiga asoslangan. Biroq, siyosiy fragmentatsiya global sinovlar va xomashyo ta'minotini murakkablashtirmoqda, operatsion foydaning yo'qligi esa tadqiqot va ishlanmalar grantlari bilan qoplanmoqda.
%20P%2FE%20multiplikatori&width=1200&height=400&colorIndex=0&v=mwejrfjc.e5f-7d7lczk&start=20220704&end=20261113&filename=GURU_Markets_-_HCWB_-_HCW-Biologics-Inc._-_PE-Multiple "HCWB: HCW Biologics Inc Biznesning o‘zini qoplash muddati 04.07.2022 - 13.11.2026 | 👁️GURU.Markets👁️")
HCW Biologics, Inc. (HCWB) kompaniyasining tahliliy kesimlari
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati HCW Biologics Inc.|HCWB - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati HCW Biologics Inc|HCWB - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati HCW Biologics Inc.|HCWB - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz HCW Biologics|Oraliq qoplash koeffitsiyenti hcwbiologics.com
- foyda va bozor multiplikatorlari tafsilotlari:
HCWB - Sof foyda|Kelajakdagi foyda HCW Biologics Inc.|HCWB - Narx-foyda koeffitsiyenti|Prognoz qilingan narxning foydaga nisbati HCW Biologics Inc|HCWB - Narx-foyda va o‘sish multiplikatori|Biznes qiymatining amortizatsiya chegirilishidan oldingi operatsion foydaga nisbati HCW Biologics Inc.|HCWB - EBITDA operatsion foydasi|So'nggi o'n ikki oy davomida bir aksiya uchun foyda HCW Biologics|HCWB - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi o'n ikki oy davomida bir aksiya uchun sof foydaning yillik o'zgarishi hcwbiologics.com|HCWB - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yilda bir aksiya uchun sof foydaning kutilayotgan o'sishi HCW Biologics Inc.
Kompaniyaning har tomonlama tahlili:hcwbiologics.com HCWB
P/E koeffitsiyenti bozor kapitalizatsiyasini sof foyda bilan solishtirish orqali aktivning investitsiyaviy jozibadorligini belgilaydi. Ushbu metrika investitsiyalarning qoplanish muddatini o'lchab, biznesning haddan tashqari qimmat yoki past baholanganligini bildiradi. Narx-foyda nisbatini tahlil qilish operatsion xarajatlarning daromadlilikka ta'sirini kuzatish imkonini beradi. HCW Biologics Inc. (HCWB) uchun ushbu ko'rsatkich kelajakdagi daromadlar qiymatini aks ettiradi. Noyob proteinlarning patent himoyasi raqobatchilar uchun to'siqlarni yaratib, kompaniyaning fundamental qiymatini qo'llab-quvvatlaydi.
Muhim raqobatchilar
P/E multiplikatori argenx.com|Narx-foyda koeffitsiyenti BNTX (BioNTech)|ABVX (ABIVAX) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ADMA (ADMA Bio)|Biznesning o‘zini qoplash muddati Protagonist Corp (PTGX)|IMVT - Narxning foydaga nisbati|kiniksa.com (KNSA) - Narx-foyda koeffitsiyenti|Grifols (GRFS) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Adaptive Biotech|Narx-foyda koeffitsiyenti CLDX|P/E multiplikatori Aurinia Corp|Narxning foydaga nisbati BioCryst (BCRX)|veratx.com - Narx-foyda multiplikatori|P/E multiplikatori DNTH (Dianthus Therapeutics, Inc.)|Pharvaris NV (PHVS) - Kapitalizatsiyaning foydaga nisbati|AbCellera Bio - P/E multiplikatori|Kompaniya qiymatining sof foydaga nisbati TRML (Tourmaline)|PGEN: P/E multiplikatori|Narx-foyda koeffitsiyenti pharming.com|Narx-foyda koeffitsiyenti NKTR|Narx-foyda koeffitsiyenti Upstream Bio, Inc. (UPB)|Narx-foyda koeffitsiyenti ZBIO (Zenas Biopharma, Inc.)|IMNM (Immunome Bio) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori GOSS (Gossamer Bio, Inc.)|kalvista.com - Narxning foydaga nisbati|Septerna - P/E multiplikatori|Biznesning o‘zini qoplash muddati Pieris Pharma PVLA|Savara Corp (SVRA) - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati Rigel Corp (RIGL)|Narxning foydaga nisbati AnaptysBio, Inc.|Narxning foydaga nisbati ATXS|Narxning foydaga nisbati enGene (ENGN)|RAPT - Kapitalizatsiyaning foydaga nisbati|P/E multiplikatori JBIO (Aerovate Therapeutics)|Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti Aclaris Therapeutics, Inc|Kyverna Therapeutics - P/E multiplikatori|Biznesning o‘zini qoplash muddati tizianalifesciences.com TLSA|CABA: P/E multiplikatori|Narx-foyda koeffitsiyenti Ventyx Biosciences Inc.|Narxning foydaga nisbati Theratechnologies Inc|Avalo Therapeutics Inc (AVTX) - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti ELDN (Eledon Pharmaceuticals)|AGEN (agenusbio.com) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori CLYM (Climb Bio)|Biznesning o‘zini qoplash muddati Zura Bio Ltd (ZURA)|ATYR - Narxning foydaga nisbati|ADAG (Adagene) - Narx-foyda multiplikatori|IMA: P/E multiplikatori|Narx-foyda koeffitsiyenti Shattuck Labs|Narx-foyda koeffitsiyenti EQ|Connect Pharma (CNTB) - Biznesning o‘zini qoplash muddati|P/E multiplikatori IMUX|ATRA (atarabio.com) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori IFRX (InflaRx)|XFOR - Narx-foyda koeffitsiyenti|ACET: Narx-foyda koeffitsiyenti|Celularity Inc. (CELU) - Narx-foyda koeffitsiyenti|INMB: P/E multiplikatori|BRNS (Barinthus Biotherapeutics Corp) - Narxning foydaga nisbati|Narxning foydaga nisbati Kezar Life Sciences|sabbiotherapeutics.com - Kapitalizatsiyaning sof foydaga nisbati|P/E multiplikatori AKTX|ENLV (enlivex.com) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori QTTB (Q32 Bio)|P/E multiplikatori GeoVax Corp GOVX|EDSA - Narxning foydaga nisbati|Kompaniya qiymatining sof foydaga nisbati IBIO (ibioinc.com)|carismatx.com (CARM) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti XTL Biopharmaceuticals Ltd|BOLT (Bolt Biotherapeutics Inc.) - P/E multiplikatori|P/E multiplikatori Aptevo|Narx-foyda koeffitsiyenti AIM (AIM ImmunoTech Inc.)|ADTX (aditxt.com) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori GRI (GRI Bio)|Biznesning o‘zini qoplash muddati XORTX Therapeutics Inc (XRTX)|HIND - Narxning foydaga nisbati|Revelation Biosciences Corp (REVB) - Narx-foyda koeffitsiyenti|Indaptus Therapeutics (INDP) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti scinai.com|Narx-foyda koeffitsiyenti CALI|P/E multiplikatori Affimed Therapeutics|Narxning foydaga nisbati Allakos Inc. (ALLK)|hookipapharma.com - Narx-foyda multiplikatori|P/E multiplikatori IGMS (IGM Biosciences)|iteostherapeutics.com (ITOS) - Kapitalizatsiyaning foydaga nisbati|Ocean Biomedical - P/E multiplikatori|Kompaniya qiymatining sof foydaga nisbati TCBP (TC BioPharm (Holdings) Plc)|THRD: P/E multiplikatori
